Naclof (Diclofenac Sodium)

Diclofenac Sodium, the active ingredient in Naclof, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an ophthalmic solution for ocular use. It reduces inflammation and pain in eye tissues after surgery or in allergic conditions. GNH USA supplies Naclof as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Diclofenac Sodium ophthalmic solution is used to manage inflammation and pain in ocular conditions.

Post‑operative ocular inflammation: reduces swelling and discomfort after eye surgery. Post‑operative ocular pain: alleviates pain following cataract or refractive procedures. Allergic conjunctivitis: helps control inflammation and itching associated with allergic eye reactions.

Adverse reactions may occur with ocular diclofenac use.

Common Side Effects: - Burning or stinging sensation upon instillation. - Redness of the conjunctiva. - Increased tearing or watery eyes. - Blurred vision temporarily. - Foreign body sensation. - Mild eye irritation.

Serious or Rare Side Effects: - Corneal ulceration or perforation. - Severe allergic reaction such as angioedema. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Vision loss or significant visual impairment. - Marked increase in intra‑ocular pressure. - Persistent or worsening inflammation despite therapy.

Before using Naclof, consider the following safety measures.

Assess ocular surface health: ensure no active infection or corneal defects. Avoid use in patients with known hypersensitivity to diclofenac or other NSAIDs. Do not combine with other ocular NSAID preparations without medical guidance. Monitor for signs of corneal toxicity or delayed healing. Avoid contact lens wear during treatment unless advised by an eye care professional. Store at room temperature: keep in the original container, protect from light and moisture.

Diclofenac Sodium ophthalmic solution can interact with other medications.

Major Interactions (Avoid): - Concurrent use with other ocular NSAIDs: increased risk of corneal toxicity. - Systemic NSAIDs: additive systemic exposure may raise bleeding risk. - Anticoagulants (e.g., warfarin): potential for enhanced ocular bleeding.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may mask signs of infection. - Contact lens solutions containing preservatives: may increase ocular irritation. - Systemic corticosteroids: may affect wound healing and inflammation control.